Plain-English translation of NCT05792722 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When bladder cancer requires surgical removal of the bladder, doctors need to decide how to best perform this surgery. This trial is testing whether a prostate capsule-sparing surgical approach — which aims to preserve more of the prostate tissue — works as well as a nerve-sparing approach in terms of cancer control, while potentially improving sexual and urinary function afterward.
After bladder removal surgery, many men experience problems with sexual function and urinary control. This trial exists to see if protecting more of the prostate during surgery might help patients maintain better quality of life without increasing the risk that cancer will return.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two surgical groups. Both groups will have bladder removal surgery, but using slightly different surgical techniques. After surgery, you'll visit the clinic every 3 months for 2 years for standard follow-up care, including blood tests, imaging, and questionnaires about your sexual and urinary function to help doctors understand how well each approach works.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States